91
Study in the country will be conducted by Unifesp and will involve 2,000 people
Brazil was one of the countries chosen to test the effectiveness of the vaccine developed by the University of Oxford against Covid-19. Two thousand people will participate in the tests, carried out with the support of the Ministry of Health. The approval of the procedure by Anvisa (National Health Surveillance Agency) was published in the Official Gazette.
In São Paulo, the tests will be conducted by the Reference Center for Special Immunobiologicals (Crie) of Unifesp (Federal University of São Paulo).
Read more in Folha de S. Paulo
